.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Federal Trade Commission
Teva
Julphar
Mallinckrodt
Colorcon
Chubb
Fuji
Farmers Insurance

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022201

« Back to Dashboard
NDA 022201 describes FIRMAGON, which is a drug marketed by Ferring and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the FIRMAGON profile page.

The generic ingredient in FIRMAGON is degarelix acetate. One supplier is listed for this compound. Additional details are available on the degarelix acetate profile page.

Summary for NDA: 022201

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:3
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022201

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FIRMAGON
degarelix acetate
POWDER;SUBCUTANEOUS 022201 NDA Ferring Pharmaceuticals Inc. 55566-8303 55566-8303-1 1 KIT in 1 CARTON (55566-8303-1) * 4 mL in 1 VIAL, GLASS * 4.2 mL in 1 SYRINGE
FIRMAGON
degarelix acetate
POWDER;SUBCUTANEOUS 022201 NDA Ferring Pharmaceuticals Inc. 55566-8403 55566-8403-1 1 KIT in 1 CARTON (55566-8403-1) * 3 mL in 1 VIAL, GLASS * 3 mL in 1 SYRINGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;SUBCUTANEOUSStrengthEQ 80MG BASE/VIAL
Approval Date:Dec 24, 2008TE:RLD:Yes
Patent:► SubscribePatent Expiration:May 18, 2021Product Flag?YSubstance Flag?YDelist Request?
Patented Use:GNRH ANTAGONIST INDICATED FOR TREATMENT OF PATIENTS WITH ADVANCED PROSTATE CANCER
Patent:► SubscribePatent Expiration:Apr 27, 2032Product Flag?Substance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Feb 10, 2029Product Flag?Substance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
US Department of Justice
Argus Health
Healthtrust
Merck
Fuji
UBS
Medtronic
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot